RAS(ON) Therapies on the Horizon to Address KRAS Resistance: Highlight on a Phase III Clinical Candidate Daraxonrasib (RMC-6236)

  • Zonghui Ma
  • , Mingxiang Zhou
  • , Qiang Shen
  • , Jia Zhou

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)12287-12292
Number of pages6
JournalJournal of medicinal chemistry
Volume68
Issue number12
DOIs
StatePublished - Jun 26 2025

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this